🎓 Small Cap Academy
Learn to trade. Get better every day. Level up from Bronze to Master Trader.
Float
8M shares
Catalyst
FDA Fast Track Designation
Volume
125M (vs 5M avg)
This case study is for educational purposes only. It is not a recommendation to buy or sell any security.
What Happened?
VistaGen received FDA Fast Track designation for its anxiety drug. The stock had only 8 million shares in the float. When the news hit pre-market, the stock gapped from $3.20 to $9.50 — a 197% move in a single day.
Why It Moved
Three forces converged: (1) A genuine binary catalyst — Fast Track designation materially improves the drug's path to market. (2) Extremely low float — only 8M shares meant any demand caused explosive moves. (3) High short interest — short sellers were caught off guard and forced to cover, amplifying the rally.
Risk Factors
The move was parabolic and unsustainable. Within 3 days the stock gave back 60% as profit-taking and dilution fears set in. Biotech catalysts are binary — negative FDA news would have sent the stock crashing. Many traders who chased the top got trapped.
Lessons Learned
Binary catalysts on low float stocks create the biggest moves. But parabolic moves mean revert — have an exit plan. The first hour after the open is where the biggest moves happen. Chasing after the initial spike is the most common way traders lose money on these setups.